Inhibitor mediated protein degradation

Chemistry and Biology

Volumn 19, Issue 5, 2012, Pages 629-637

  Long, Marcus J C ^a   Gollapalli, Deviprasad R ^a   Hedstrom, Lizbeth ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DERIVATIVE; BENZOFURAZAN DERIVATIVE; DIHYDROFOLATE REDUCTASE; ETACRYNIC ACID; GLUTATHIONE TRANSFERASE; PROTEASOME; TRIMETHOPRIM; UBIQUITIN;

ANIMAL CELL; ARTICLE; CELL LYSATE; CELL VIABILITY; CONTROLLED STUDY; ENZYME SYNTHESIS; ESCHERICHIA COLI; FLOW CYTOMETRY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UBIQUITINATION;

DRUG DESIGN; GLUTATHIONE TRANSFERASE; HELA CELLS; HUMANS; PHENYLCARBAMATES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; TETRAHYDROFOLATE DEHYDROGENASE; UBIQUITIN;

EID: 84861628558     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2012.04.008     Document Type: Article

References (60)

1. A. Aherne, A. Kennan, P.F. Kenna, N. McNally, D.G. Lloyd, I.L. Alberts, A.S. Kiang, M.M. Humphries, C. Ayuso, and P.C. Engel On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa Hum. Mol. Genet. 13 2004 641 650
2. G. Asher, N. Reuven, and Y. Shaul 20S proteasomes and protein degradation "by default" Bioessays 28 2006 844 849
3. L.A. Banaszynski, L.C. Chen, L.A. Maynard-Smith, A.G. Ooi, and T.J. Wandless A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules Cell 126 2006 995 1004
4. V. Bernier, M. Lagacé, D.G. Bichet, and M. Bouvier Pharmacological chaperones: potential treatment for conformational diseases Trends Endocrinol. Metab. 15 2004 222 228
5. K.M. Bonger, L.C. Chen, C.W. Liu, and T.J. Wandless Small-molecule displacement of a cryptic degron causes conditional protein degradation Nat. Chem. Biol. 7 2011 531 537
6. N. Breusing, and T. Grune Regulation of proteasome-mediated protein degradation during oxidative stress and aging Biol. Chem. 389 2008 203 209
7. M. Calligé, and H. Richard-Foy Ligand-induced estrogen receptor alpha degradation by the proteasome: new actors? Nucl. Recept. Signal. 4 2006 e004
8. N.T. Calloway, M. Choob, A. Sanz, M.P. Sheetz, L.W. Miller, and V.W. Cornish Optimized fluorescent trimethoprim derivatives for in vivo protein labeling ChemBioChem 8 2007 767 774
9. M.J. Clague, and S. Urbé Ubiquitin: same molecule, different degradation pathways Cell 143 2010 682 685
10. R.A. Copeland, D.L. Pompliano, and T.D. Meek Drug-target residence time and its implications for lead optimization Nat. Rev. Drug Discov. 5 2006 730 739
11. D.T. Dang, F. Chen, M. Kohli, C. Rago, J.M. Cummins, and L.H. Dang Glutathione S-transferase pi1 promotes tumorigenicity in HCT116 human colon cancer cells Cancer Res. 65 2005 9485 9494
12. J.H. Davis, T.A. Baker, and R.T. Sauer Engineering synthetic adaptors and substrates for controlled ClpXP degradation J. Biol. Chem. 284 2009 21848 21855
13. R.J. Deshaies, and C.A. Joazeiro RING domain E3 ubiquitin ligases Annu. Rev. Biochem. 78 2009 399 434
14. R.J. Dohmen, P. Wu, and A. Varshavsky Heat-inducible degron: a method for constructing temperature-sensitive mutants Science 263 1994 1273 1276
15. S.M. Dunn, and R.W. King Kinetics of ternary complex formation between dihydrofolate reductase, coenzyme, and inhibitors Biochemistry 19 1980 766 773
16. D. Finley Recognition and processing of ubiquitin-protein conjugates by the proteasome Annu. Rev. Biochem. 78 2009 477 513
17. P.G. Foran, N. Mohammed, G.O. Lisk, S. Nagwaney, G.W. Lawrence, E. Johnson, L. Smith, K.R. Aoki, and J.O. Dolly Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons J. Biol. Chem. 278 2003 1363 1371
18. L.G. Higgins, and J.D. Hayes Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflammatory agents Drug Metab. Rev. 43 2011 92 137
19. A. Howell Fulvestrant ('Faslodex'): current and future role in breast cancer management Crit. Rev. Oncol. Hematol. 57 2006 265 273
20. R. Hu, C. Xu, G. Shen, M.R. Jain, T.O. Khor, A. Gopalkrishnan, W. Lin, B. Reddy, J.Y. Chan, and A.N. Kong Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice Cancer Lett. 243 2006 170 192
21. Y. Hu, S. Swerdlow, T.M. Duffy, R. Weinmann, F.Y. Lee, and S. Li Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice Proc. Natl. Acad. Sci. USA 103 2006 16870 16875
22. M. Iwamoto, T. Björklund, C. Lundberg, D. Kirik, and T.J. Wandless A general chemical method to regulate protein stability in the mammalian central nervous system Chem. Biol. 17 2010 981 988
23. D.M. Janse, B. Crosas, D. Finley, and G.M. Church Localization to the proteasome is sufficient for degradation J. Biol. Chem. 279 2004 21415 21420
24. I. Jariel-Encontre, G. Bossis, and M. Piechaczyk Ubiquitin-independent degradation of proteins by the proteasome Biochim. Biophys. Acta 1786 2008 153 177
25. T. Jung, B. Catalgol, and T. Grune The proteasomal system Mol. Aspects Med. 30 2009 191 296
26. Kenten, J.H., and Roberts, S.F. (2001). Controlling protein levels in eukaryotic organisms, U.S. Patent: States, ed. Proteinix, Inc.).
27. E. Laborde Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death Cell Death Differ. 17 2010 1373 1380
28. B.H. Lee, M.J. Lee, S. Park, D.C. Oh, S. Elsasser, P.C. Chen, C. Gartner, N. Dimova, J. Hanna, and S.P. Gygi Enhancement of proteasome activity by a small-molecule inhibitor of USP14 Nature 467 2010 179 184
29. H. Lee, D. Puppala, E.Y. Choi, H. Swanson, and K.B. Kim Targeted degradation of the aryl hydrocarbon receptor by the PROTAC approach: a useful chemical genetic tool ChemBioChem 8 2007 2058 2062
30. F. Lévy, J.A. Johnston, and A. Varshavsky Analysis of a conditional degradation signal in yeast and mammalian cells Eur. J. Biochem. 259 1999 244 252
31. M.J. Long, Y. Pan, H.C. Lin, L. Hedstrom, and B. Xu Cell compatible trimethoprim-decorated iron oxide nanoparticles bind dihydrofolate reductase for magnetically modulating focal adhesion of mammalian cells J. Am. Chem. Soc. 133 2011 10006 10009
32. B. Medicherla, and A.L. Goldberg Heat shock and oxygen radicals stimulate ubiquitin-dependent degradation mainly of newly synthesized proteins J. Cell Biol. 182 2008 663 673
33. R. Nasr, V. Lallemand-Breitenbach, J. Zhu, M.C. Guillemin, and H. de Thé Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure Clin. Cancer Res. 15 2009 6321 6326
34. T.K. Neklesa, H.S. Tae, A.R. Schneekloth, M.J. Stulberg, T.W. Corson, T.B. Sundberg, K. Raina, S.A. Holley, and C.M. Crews Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins Nat. Chem. Biol. 7 2011 538 543
35. J.H. Ploemen, B. van Ommen, J.J. Bogaards, and P.J. van Bladeren Ethacrynic acid and its glutathione conjugate as inhibitors of glutathione S-transferases Xenobiotica 23 1993 913 923
36. M.R. Pratt, E.C. Schwartz, and T.W. Muir Small-molecule-mediated rescue of protein function by an inducible proteolytic shunt Proc. Natl. Acad. Sci. USA 104 2007 11209 11214
37. K. Raina, and C.M. Crews Chemical inducers of targeted protein degradation J. Biol. Chem. 285 2010 11057 11060
38. L. Raj, T. Ide, A.U. Gurkar, M. Foley, M. Schenone, X. Li, N.J. Tolliday, T.R. Golub, S.A. Carr, and A.F. Shamji Selective killing of cancer cells by a small molecule targeting the stress response to ROS Nature 475 2011 231 234
39. G. Ricci, F. De Maria, G. Antonini, P. Turella, A. Bullo, L. Stella, G. Filomeni, G. Federici, and A.M. Caccuri 7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-transferases. Mechanism of action of potential anticancer drugs J. Biol. Chem. 280 2005 26397 26405
40. D. Ringe, and G.A. Petsko What are pharmacological chaperones and why are they interesting? J. Biol. 8 2009 80
41. A. Rodriguez-Gonzalez, K. Cyrus, M. Salcius, K. Kim, C.M. Crews, R.J. Deshaies, and K.M. Sakamoto Targeting steroid hormone receptors for ubiquitination and degradation in breast and prostate cancer Oncogene 27 2008 7201 7211
42. K.M. Sakamoto, K.B. Kim, A. Kumagai, F. Mercurio, C.M. Crews, and R.J. Deshaies Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation Proc. Natl. Acad. Sci. USA 98 2001 8554 8559
43. A. Sau, F. Pellizzari Tregno, F. Valentino, G. Federici, and A.M. Caccuri Glutathione transferases and development of new principles to overcome drug resistance Arch. Biochem. Biophys. 500 2010 116 122
44. B. Shi, R. Stevenson, D.J. Campopiano, and M.F. Greaney Discovery of glutathione S-transferase inhibitors using dynamic combinatorial chemistry J. Am. Chem. Soc. 128 2006 8459 8467
45. R. Shringarpure, T. Grune, and K.J. Davies Protein oxidation and 20S proteasome-dependent proteolysis in mammalian cells Cell. Mol. Life Sci. 58 2001 1442 1450
46. J. Singh, R.C. Petter, T.A. Baillie, and A. Whitty The resurgence of covalent drugs Nat. Rev. Drug Discov. 10 2011 307 317
47. K. Stankunas, J.H. Bayle, J.E. Gestwicki, Y.M. Lin, T.J. Wandless, and G.R. Crabtree Conditional protein alleles using knockin mice and a chemical inducer of dimerization Mol. Cell 12 2003 1615 1624
48. D.C. Swinney Biochemical mechanisms of drug action: what does it take for success? Nat. Rev. Drug Discov. 3 2004 801 808
49. N. Tanahashi, Y. Murakami, Y. Minami, N. Shimbara, K.B. Hendil, and K. Tanaka Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis J. Biol. Chem. 275 2000 14336 14345
50. T. Tasaki, and Y.T. Kwon The mammalian N-end rule pathway: new insights into its components and physiological roles Trends Biochem. Sci. 32 2007 520 528
51. K.D. Tew, and D.M. Townsend Regulatory functions of glutathione S-transferase P1-1 unrelated to detoxification Drug Metab. Rev. 43 2011 179 193
52. R.K. Thimmulappa, K.H. Mai, S. Srisuma, T.W. Kensler, M. Yamamoto, and S. Biswal Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray Cancer Res. 62 2002 5196 5203
53. A.S. Waller, R.M. Sharrard, P. Berthon, and N.J. Maitland Androgen receptor localisation and turnover in human prostate epithelium treated with the antiandrogen, casodex J. Mol. Endocrinol. 24 2000 339 351
54. J.E. Whittier, Y. Xiong, M.C. Rechsteiner, and T.C. Squier Hsp90 enhances degradation of oxidized calmodulin by the 20 S proteasome J. Biol. Chem. 279 2004 46135 46142
55. B.M. Wittmann, A. Sherk, and D.P. McDonnell Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators Cancer Res. 67 2007 9549 9560
56. Y.L. Wu, X. Yang, Z. Ren, D.P. McDonnell, J.D. Norris, T.M. Willson, and G.L. Greene Structural basis for an unexpected mode of SERM-mediated ER antagonism Mol. Cell 18 2005 413 424
57. Y. Xie Structure, assembly and homeostatic regulation of the 26S proteasome J Mol Cell Biol 2 2010 308 317
58. H.C. Yen, and S.J. Elledge Identification of SCF ubiquitin ligase substrates by global protein stability profiling Science 322 2008 923 929
59. H.C. Yen, Q. Xu, D.M. Chou, Z. Zhao, and S.J. Elledge Global protein stability profiling in mammalian cells Science 322 2008 918 923
60. R. Zhang, and F. Monsma The importance of drug-target residence time Curr. Opin. Drug Discov. Devel. 12 2009 488 496